Preoperative Nivolumab in Patients With Locally Advanced Colon Cancer (T3 or T4): a Window-of-opportunity Study
Status:
Completed
Trial end date:
2019-09-02
Target enrollment:
Participant gender:
Summary
A monocentric window of opportunity study preceded by a safety run-in phase. The study
population will include locally advanced colon patients (T3 or T4).